Renaissance Capital logo

HAO News

US IPO Weekly Recap: Biotech CG Oncology pops 96% in a 7 IPO week

BTSG

Seven IPOs priced this past week, led by three that raised $100+ million. After upwardly revising the terms earlier in the week, CG Oncology (CGON) further upsized the offering and priced above the range to raise $380 million at a $1.3 billion market cap. Its sole clinical asset is initially in development for a subclass of bladder cancer and is currently in an...read more

China-based Haoxi Health Technology prices downsize US IPO at $4, the low end of the range

HAO

Haoxi Health Technology, which provides online marketing solutions in China, raised $10 million by offering 2.4 million shares at $4, the low end of the range of $4 to $5. The company offered 0.6 million fewer shares than anticipated. Haoxi provides customized marketing solutions by planning, producing, placing, and optimizing online short video ads to help its advertiser customers...read more

US IPO Weekly Recap: September IPO roster gets a boost as Arm, Instacart, and other large filers join the pipeline

ARM

The IPO calendar was quiet this past week, but the pipeline got a boost from several large deals. UK-based chip designer Arm (ARM) and grocery delivery platform Instacart (CART) led the week’s news, filing for IPOs that we estimate could raise up to $6 billion and $1 billion, respectively. Arm is expected to headline the 2023 IPO market,...read more

Chinese online marketing solutions provider Haoxi Health Technology files and sets terms for a $14 million US IPO

HAO

Haoxi Health Technology, which provides online marketing solutions in China, filed on Friday with the SEC to raise up to $14 million in an initial public offering. The Beijing, China-based company plans to raise $14 million by offering 3 million shares at a price range of $4 to $5. At the midpoint of the proposed range, Haoxi Health Technology would command a market value of $146...read more

Archived Headlines